Log in to your Inderes Free account to see all free content on this page.
Alligator Bioscience
0.259
SEK
-3 %
ATORX
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
3 following
-3%
-50.95%
-80.45%
-77.91%
-62.48%
-63.69%
-81.62%
-95.23%
-98.73%
Alligator Bioscience is a research-based biotechnology company that uses patented technology to develop biological drug candidates in inflammation and cancer. The company is active in the former part of the drug development chain. Alligator Bioscience has a global technology platform and is active in a rapidly growing segment of the pharmaceutical market - protein drugs. The company was founded in 2001 and is headquartered in Lund, Sweden.
Read moreMarket cap
196.59M SEK
Turnover
474.6K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
13.2.
2025
Annual report '24
24.4.
2025
Interim report Q1'25
ShowingAll content types
Last day of trading in warrants series TO 9 in Alligator Bioscience AB is 13 December 2024
Alligator Bioscience: BioStock: Alligator's CEO: "We are on track to secure a partnership"
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio